Insider · CIK 0001741171

O'Dowd Hugh

Reports to the SEC for 3 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001741171

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-03-31	TXMDTherapeuticsMD, Inc. · Performance Stock UnitsA Award	Chief Executive Officer	AAward	+2.13M sh	—	—	2,125,000
2022-03-23	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Chief Executive Officer	AAward	+2.13M sh	—	—	2,125,000
2021-08-31	TXMDTherapeuticsMD, Inc. · Performance Stock UnitsA Award	Chief Executive Officer	AAward	+2.75M sh	—	—	2,750,000
2021-08-31	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Chief Executive Officer	AAward	+2.75M sh	—	—	2,750,000
2020-06-09	PBYIPUMA BIOTECHNOLOGY, INC.A Award	Director	AAward	+25.7K sh	—	—	25,748
2020-05-06	Neon Therapeutics, Inc.D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−776K sh	—	—	0
2020-05-06	Neon Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−208K sh	—	—	0
2020-05-06	Neon Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−200K sh	—	—	0
2020-05-06	Neon Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−355K sh	—	—	0
2020-02-29	Neon Therapeutics, Inc.F Tax Payment	Director, President & CEO	FTax Payment	−9,783 sh	$1.50	−$14.7K	776,085
2020-01-12	Neon Therapeutics, Inc.A Award	Director, President & CEO	AAward	+240K sh	—	—	785,868
2019-10-15	PBYIPUMA BIOTECHNOLOGY, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+85.2K sh	—	—	85,201
2019-02-27	Neon Therapeutics, Inc.A Award	Director, President & CEO	AAward	+100K sh	—	—	545,868
2019-02-27	Neon Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+200K sh	—	—	200,000
2018-08-20	Neon Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+18.9K sh	$2.65	+$50K	445,868
2018-08-20	Neon Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−18.9K sh	—	—	314,607

Recent filings

Accepted (ET)
Mar 314
O'Dowd Hugh0001209191-22-021794
SEC(opens sec.gov)
Mar 284
O'Dowd Hugh0001209191-22-021211
SEC(opens sec.gov)
Aug 314
O'Dowd Hugh0001209191-21-054119
SEC(opens sec.gov)
Jun 114
O'Dowd Hugh0001209191-20-036168
SEC(opens sec.gov)
May 64
O'Dowd Hugh0001694187-20-000062
SEC(opens sec.gov)
Mar 24
O'Dowd Hugh0001694187-20-000027
SEC(opens sec.gov)
Jan 134
O'Dowd Hugh0001694187-20-000007
SEC(opens sec.gov)
Oct 174
O'Dowd Hugh0001209191-19-053442
SEC(opens sec.gov)
Mar 14
O'Dowd Hugh0001694187-19-000012
SEC(opens sec.gov)
Aug 224
O'Dowd Hugh0001104659-18-053206
SEC(opens sec.gov)

Companies

Address

C/O NEON THERAPEUTICS, INC. 40 ERIE STREET, SUITE 110

CAMBRIDGE, MA, 02139